Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Synergy Pharma (SGYP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart
Realtime quote and/or trade prices are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 468,654
  • Shares Outstanding, K 246,660
  • Annual Sales, $ 0 K
  • Annual Income, $ -198,610 K
  • 36-Month Beta 1,061.37
  • Price/Sales 54.87
  • Price/Cash Flow N/A
  • Price/Book 0.00

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.68 +14.07%
on 11/15/17
3.19 -39.92%
on 11/06/17
-0.73 (-27.68%)
since 10/24/17
3-Month
1.68 +14.07%
on 11/15/17
3.57 -46.32%
on 10/05/17
-1.13 (-37.17%)
since 08/24/17
52-Week
1.68 +14.07%
on 11/15/17
7.15 -73.20%
on 01/31/17
-3.48 (-64.51%)
since 11/23/16

Most Recent Stories

More News
Pre-Market Technical Recap on Drug Makers Stocks -- Synergy Pharma, Novo Nordisk, United Therapeutics, and Depomed

If you want a Stock Review on SGYP, NVO, UTHR, or DEPO then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. DailyStockTracker.com redirects investors' attention...

NVO : 52.20 (+0.69%)
SGYP : 1.91 (+0.53%)
UTHR : 124.25 (-0.92%)
DEPO : 6.29 (-0.16%)
Synergy Pharmaceuticals Announces Pricing of Offering of Common Stock and Warrants

Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal therapies, today announced the pricing of...

SGYP : 1.91 (+0.53%)
Today's Research Reports on Stocks to Watch: Infinity Pharmaceuticals and Synergy Pharmaceuticals

NEW YORK, NY / ACCESSWIRE / November 13, 2017 / Both Infinity Pharmaceuticals and Synergy Pharmaceuticals closed in the red on Friday. Shares of Infinity closed down nearly 14% despite encouraging results...

INFI : 2.06 (unch)
SGYP : 1.91 (+0.53%)
Synergy Pharmaceuticals Reports Third Quarter 2017 Financial Results and Business Update

--Total net revenues up 117%

SGYP : 1.91 (+0.53%)
Synergy Pharmaceuticals, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / November 9, 2017 / Synergy Pharmaceuticals, Inc. (NASDAQ: SGYP) will be discussing their earnings results in their Q3 Earnings Call to be held on November 9, 2017 at 4:30 PM...

SGYP : 1.91 (+0.53%)
Market Trends Toward New Normal in Public Service Enterprise Group, Rigel Pharma, National Oilwell Varco, Ironwood Pharma, Express Scripts, and Synergy Pharma - Emerging Consolidated Expectations, Analyst Ratings

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Public Service Enterprise Group...

PEG : 51.40 (-0.06%)
NOV : 31.79 (-0.47%)
IRWD : 15.65 (+0.26%)
ESRX : 61.29 (-1.34%)
RIGL : 4.22 (-0.71%)
SGYP : 1.91 (+0.53%)
Allergan (AGN) Tops Q3 Earnings Estimates, Tweaks 2017 View

Allergan (AGN) beat expectations for earnings while delivering in-line revenues in Q3. While the company slightly lowered its sales guidance, it raised the upper end of the earnings guidance.

AGN : 174.02 (-0.46%)
SHPG : 148.16 (-1.08%)
TEVA : 13.68 (+1.48%)
SGYP : 1.91 (+0.53%)
Synergy Pharmaceuticals to Report Third Quarter 2017 Financial Results and Host Conference Call and Webcast

Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) today announced it intends to release third quarter 2017 financial results after the NASDAQ market close on Thursday, November 9, 2017. The Company...

SGYP : 1.91 (+0.53%)
Synergy Pharmaceuticals Presents Results from Study Examining Patient and Physician Perceptions and Experiences with Irritable Bowel Syndrome with Constipation (IBS-C)

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) announced today new findings highlighting the frustration of patients suffering from irritable bowel syndrome with constipation (IBS-C) and the...

SGYP : 1.91 (+0.53%)
Technical Snapshots for These Drug Makers Stocks -- SciClone Pharma, Synergy Pharma, Novo Nordisk, and United Therapeutics

If you want a Stock Review on SCLN, SGYP, NVO, or UTHR then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. Today's investors' attention is directed to...

SCLN : 11.15 (unch)
NVO : 52.20 (+0.69%)
SGYP : 1.91 (+0.53%)
UTHR : 124.25 (-0.92%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More

Business Summary

Synergy Pharmaceuticals, Inc. is a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. Its lead drug candidate plecanatide is a guanylyl cyclase C receptor agonist, to treat GI disorders, primarily chronic constipation and constipation-predominant-...

See More

Key Turning Points

2nd Resistance Point 1.96
1st Resistance Point 1.93
Last Price 1.91
1st Support Level 1.88
2nd Support Level 1.86

See More

52-Week High 7.15
Fibonacci 61.8% 5.06
Fibonacci 50% 4.41
Fibonacci 38.2% 3.77
Last Price 1.91
52-Week Low 1.68

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart